Skip to content
  • Sunday, 26 July 2026
  • 2:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Doherty Institute Researchers Unveil Groundbreaking Assay for Rapid, Precise Detection of Four STIs and Antibiotic Resistance
Clinical Diagnostics & Pathology

Doherty Institute Researchers Unveil Groundbreaking Assay for Rapid, Precise Detection of Four STIs and Antibiotic Resistance

Reynand Amr Wu Mar 25, 2026 0

Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have developed a portable, point-of-care diagnostic tool capable…

Read More
Data Science & Bioinformatics

Google DeepMind Unveils SynthID: A Groundbreaking Solution for AI Content Provenance and Combating Synthetic Media Misinformation

Evan Lee Salim Mar 20, 2026 0

In an era increasingly defined by the proliferation of sophisticated artificial intelligence, Google DeepMind has introduced SynthID, a cutting-edge framework…

Read More
Biotech & Genetic Research

A Groundbreaking DNA Test from Hebrew University Revolutionizes Leishmaniasis Tracking and Global Disease Surveillance.

Jia Lissa Mar 20, 2026 0

The Hebrew University of Jerusalem has unveiled a pioneering molecular diagnostic system, spearheaded by researchers at its Koret School of…

Read More
Pharmaceutical R&D

Quintessence Biotech Unveils Groundbreaking Artificial Cell Technology to Revolutionize Cell and Gene Therapy Manufacturing

Teuku Ryan Mar 19, 2026 0

Quintessence Biotech has introduced a pioneering bio-separation tool, dubbed DACS (Dynamic Artificial Cell System), designed to significantly alleviate the manufacturing…

Read More

Posts pagination

1 … 4 5
UCB Acquires Candid Therapeutics for Up to $2.2 Billion to Bolster Autoimmune Disease Pipeline with Novel T-Cell EngagersBrain-Based Signaling Pathway Identified as Key Mechanism for Metformin in Controlling Blood Glucose LevelsBristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid TumorsInternational Research Team Identifies Distinct Biological Subtypes of Autism through Brain Connectivity Patterns and Genetic Markers
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ